NCT03050112View on ClinicalTrials.gov

Long-term Quality of Life of Patients With a Congenital Heart Disease, Treated by Surgery in Adulthood at the Brugmann Hospital.

NACompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

February 14, 2017

Primary Completion Date

June 1, 2017

Study Completion Date

June 1, 2017

Conditions
Congenital Heart Disease
Interventions
OTHER

MacNew questionnaire

Patients will be asked to fill in the MacNew questionnaire on quality of life (phone contact).

Trial Locations (1)

1020

CHU Brugmann, Brussels

All Listed Sponsors
lead

Pierre Wauthy

OTHER

NCT03050112 - Long-term Quality of Life of Patients With a Congenital Heart Disease, Treated by Surgery in Adulthood at the Brugmann Hospital. | Biotech Hunter | Biotech Hunter